Page 6 - Pnt O News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pnt o. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pnt O Today - Breaking & Trending Today

POINT Biopharma Global (NASDAQ:PNT) Sees Strong Trading Volume

POINT Biopharma Global Inc. (NASDAQ:PNT – Get Free Report) shares saw unusually-high trading volume on Tuesday . Approximately 956,332 shares traded hands during mid-day trading, an increase of 6% from the previous session’s volume of 904,998 shares.The stock last traded at $12.38 and had previously closed at $12.38. Analysts Set New Price Targets PNT has […] ....

Piper Sandler , William Blair , Biopharma Global Company Profile , Point Biopharma Global Inc , Bellevue Group , Vanguard Group Inc , Biopharma Global Inc , Balyasny Asset Management , Get Free Report , Global Stock Down , Street Corp , Asset Management , Global Company , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt ,

POINT Biopharma Global (NASDAQ:PNT) Stock Rating Lowered by William Blair

William Blair cut shares of POINT Biopharma Global (NASDAQ:PNT – Free Report) from an outperform rating to a market perform rating in a research note issued to investors on Tuesday, Marketbeat Ratings reports. Other research analysts have also recently issued research reports about the company. Truist Financial cut POINT Biopharma Global from a buy rating […] ....

Piper Sandler , William Blair , Raymond James , Jefferies Financial Group , Biopharma Global Inc , Clear Harbor Asset Management , Biopharma Global Company Profile , Beutel Goodman Co Ltd , E Fund Management Co , Tower Research Capital , Free Report , Marketbeat Ratings , Financial Group , Global Trading Down , Get Free Report , Research Capital , Harbor Asset Management , Global Company , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt ,

POINT Biopharma Global (NASDAQ:PNT) Downgraded by Guggenheim

Guggenheim cut shares of POINT Biopharma Global (NASDAQ:PNT – Free Report) from a buy rating to a neutral rating in a research note released on Wednesday morning, FlyOnTheWall reports. Several other analysts also recently weighed in on the company. Jefferies Financial Group downgraded POINT Biopharma Global from a buy rating to a hold rating in […] ....

Raymond James , William Blair , Piper Sandler , Biopharma Global Company Profile , Beutel Goodman Co Ltd , Jefferies Financial Group , Biopharma Global Inc , Capital Management , Tower Research Capital , Principal Financial Group Inc , Free Report , Financial Group , Global Trading Down , Get Free Report , Research Capital , Global Company , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt ,